|
mendelian randomization |
26 |
|
vitamin d |
22 |
|
testosterone |
14 |
|
chinese |
13 |
|
hypertension |
13 |
|
secondary prevention |
13 |
|
ischemic stroke |
12 |
|
myocardial infarction |
12 |
|
recurrence |
12 |
|
sex disparity |
11 |
|
exome chip |
10 |
|
type 2 diabetes |
10 |
|
atrial fibrillation |
9 |
|
berberine |
9 |
|
young-onset ischemic stroke |
9 |
|
mendelian randomization analysis |
8 |
|
diabetes |
7 |
|
insulin resistance |
7 |
|
qt interval |
7 |
|
blood pressure |
6 |
|
cardiovascular disease |
6 |
|
ischemic heart disease |
6 |
|
cardiovascular risk factors |
5 |
|
covid-19 |
5 |
|
estrogen |
5 |
|
gene |
5 |
|
menarche |
5 |
|
menarcheal age |
5 |
|
meta-analysis |
5 |
|
puberty |
5 |
|
randomized controlled trial |
5 |
|
women |
5 |
|
air pollution |
4 |
|
blood glucose |
4 |
|
causal effect |
4 |
|
efficacy |
4 |
|
instrumental variable estimate |
4 |
|
kidney function |
4 |
|
risk factors |
4 |
|
safety |
4 |
|
selection bias |
4 |
|
sex-specific effect |
4 |
|
treatment |
4 |
|
ace inhibitor |
3 |
|
anti-androgen |
3 |
|
aspartate |
3 |
|
competing risk |
3 |
|
diabetes mellitus |
3 |
|
e-cigarettes |
3 |
|
glucose |
3 |
|
glycated hemoglobin |
3 |
|
immune function |
3 |
|
inflammation |
3 |
|
instrumental variable analysis |
3 |
|
lifespan |
3 |
|
placebo-controlled trial |
3 |
|
pm10 |
3 |
|
random allocation |
3 |
|
randomization mr |
3 |
|
shared etiology |
3 |
|
smoking |
3 |
|
unsaturated fatty acid |
3 |
|
adolescents |
2 |
|
androgen |
2 |
|
androgens |
2 |
|
antihypertensive drugs |
2 |
|
antihypertensives |
2 |
|
arachidonic acid |
2 |
|
asthma |
2 |
|
atherosclerotic cardiovascular disease |
2 |
|
big data |
2 |
|
cardiovascular |
2 |
|
cerebrovascular accident |
2 |
|
chronic disease |
2 |
|
chronic diseases |
2 |
|
chronic kidney disease |
2 |
|
clinical trial (topic) |
2 |
|
coagulation |
2 |
|
dhea-s |
2 |
|
dietary intake |
2 |
|
early-life exposure |
2 |
|
fads1 gene |
2 |
|
fads2 gene |
2 |
|
folate |
2 |
|
gender difference |
2 |
|
genetic analysis |
2 |
|
healthspan |
2 |
|
heart diseases |
2 |
|
heart rate |
2 |
|
human |
2 |
|
linoleic acid |
2 |
|
lipids |
2 |
|
men |
2 |
|
mendelian randomisation |
2 |
|
obesity |
2 |
|
proteomics |
2 |
|
renal function |
2 |
|
sex |
2 |
|
sex hormone binding globulin |
2 |
|
systematic review |
2 |
|
thrombin |
2 |
|
von willebrand factor |
2 |
|
white blood cell |
2 |
|
3-hydroxyisobutyrate |
1 |
|
ace inhibitors |
1 |
|
acetate |
1 |
|
adiposity |
1 |
|
benign prostatic hyperplasia |
1 |
|
beta-blockers |
1 |
|
branch-chain amino acids |
1 |
|
breast cancer |
1 |
|
calcium channel blockers |
1 |
|
cancer |
1 |
|
citation bias |
1 |
|
coarse particle |
1 |
|
coronary artery disease |
1 |
|
european population |
1 |
|
genetically predicted |
1 |
|
heart disease |
1 |
|
hormones |
1 |
|
insulin |
1 |
|
interventions |
1 |
|
iron status |
1 |
|
lipid profiles |
1 |
|
longevity |
1 |
|
mental disorders |
1 |
|
middle-aged and older adults |
1 |
|
nitrogen oxides |
1 |
|
non-alcoholic fatty liver disease |
1 |
|
pm2.5 |
1 |
|
processed meat |
1 |
|
red meat |
1 |
|
sex-specific |
1 |
|
short-chain fatty acid |
1 |
|
sibling controls |
1 |
|
survival bias |
1 |
|
two-sample mendelian randomization |
1 |
